A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
united states substance abuse and mental health services administration
administración de salud mental y abuso de sustancias de los eeuu
note for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance
note for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance
titolo delle linee guida definition of a new biological active substance in terms of active, passive immunity and immunomodulators which then constitute a new active ingredient
definition of a new biological active substance in terms of active, passive immunity and immunomodulators which then constitute a new active ingredient
efsa scientific report (2008) 136, conclusion regarding the peer review of the pesticide risk assessment of the active substance bromuconazole, conclusioni approvate il 26 marzo 2008.
efsa scientific report —informe científico de la efsa— (2008) 136, «conclusion regarding the peer review of the pesticide risk assessment of the active substance bromuconazole finalised 26 march 2008» (conclusión relativa a la revisión inter pares de la evaluación del riesgo de la sustancia activa bromuconazol utilizada como plaguicida, fecha de finalización: 26 de marzo de 2008).
questa sostanza è identificata da sda substance name: c12-c18 alkyl alcohol sulfuric acid sodium salt e sda reporting number: 16-062-04
esta sustancia está identificada por sda substance name: c12-c18 alkyl alcohol sulfuric acid sodium salt y sda reporting number: 16-062-04 emulsificante/tensoactivo/limpiador/espumante
note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/ preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing α - and β -asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products concept paper on the levels of scientific evidence required for the authorisation of well-established use and traditional herbal medicinal products core-data on urticae radix core-data on lini semen core-data on rosmarini folium cum flore core-data on primulae radix
concept paper on the levels of scientific evidence required for the authorisation of well-established use and traditional herbal medicinal products core-data on urticae radix core-data on lini semen core-data on rosmarini folium cum flore core-data on primulae radix
